{"prompt": "['Protocol VX18-445-109, Version 1.0', 'Page 59 of 60', '15', 'PROTOCOL SIGNATURE PAGES', '15.1', 'Sponsor Signature Page', 'Protocol #:', 'VX18-445-109', 'Version #:', '1.0', 'Version Date:', '30 May 2019', 'Study Title: A Phase 3b, Randomized, Double-blind, Controlled Study Evaluating the Efficacy', 'and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for', 'F508del', 'This Clinical Study Protocol has been reviewed and approved by the sponsor.', 'Vertex Pharmaceuticals Incorporated']['Protocol VX18-445-109, Version 1.0', 'Page 60 of 60', '15.2', 'Investigator Signature Page', 'Protocol #:', 'VX18-445-109', 'Version #:', '1.0', 'Version Date:', '30 May 2019', 'Study Title: A Phase 3b, Randomized, Double-blind, Controlled Study Evaluating the Efficacy', 'and Safety of VX-445/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects, Homozygous for', 'F508del', 'I have read Protocol VX18-445-109, Version 1.0, and agree to conduct the study according to its', 'terms. I understand that all information concerning VX-445, tezacaftor, and ivacaftor and this', 'protocol supplied to me by Vertex Pharmaceuticals Incorporated (Vertex) is confidential.', 'Printed Name', 'Signature', 'Date', 'Vertex Pharmaceuticals Incorporated']\n\n###\n\n", "completion": "END"}